0001209191-21-041617.txt : 20210617
0001209191-21-041617.hdr.sgml : 20210617
20210617175730
ACCESSION NUMBER: 0001209191-21-041617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fenton Mary Kay
CENTRAL INDEX KEY: 0001378589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39575
FILM NUMBER: 211026161
MAIL ADDRESS:
STREET 1: ACHILLION PHARMACEUTICALS
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncorus, Inc.
CENTRAL INDEX KEY: 0001671818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473779757
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 KENDALL STREET
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-425-9200
MAIL ADDRESS:
STREET 1: 450 KENDALL STREET
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-16
0
0001671818
Oncorus, Inc.
ONCR
0001378589
Fenton Mary Kay
C/O ONCORUS, INC.
50 HAMPSHIRE STREET, SUITE 401
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
16.55
2021-06-16
4
A
0
12500
0.00
A
2031-06-15
Common Stock
12500
12500
D
The option shall vest in 12 equal monthly installments commencing on July 16, 2021, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2021-06-17